STOCKWATCH
·
Pharmaceuticals
Promoter Reclassification15 May 2026, 12:26 pm

Hester Bio: Board Approves Promoter Reclassification Request

AI Summary

The Board of Directors of Hester Biosciences Ltd approved the submission of an application to the National Stock Exchange of India Limited and BSE Limited for obtaining a No Objection Certificate for the re-classification requests received from Mr. Ravin Gandhi and Ms. Bela Gandhi (part of Promoters). The board confirmed that Mr. Ravin Gandhi and Ms. Bela Gandhi satisfy the conditions specified under Regulation 31A(3)(b) of the SEBI LODR Regulations and continue to comply with the requirements specified in Regulation 31A (3) and (4) of the Listing Regulations at all times. The re-classification is subject to the receipt of no objection from the Stock Exchanges in terms of Regulation 31A of Listing Regulations.

Key Highlights

  • Hester Bio's board approved re-classification requests from promoters Ravin and Bela Gandhi.
  • Application will be submitted to NSE and BSE for No Objection Certificate.
  • Promoters meet conditions under Regulation 31A(3)(b) of SEBI LODR Regulations.
  • Re-classification is subject to stock exchange approval per Regulation 31A.
HESTERBIO
Pharmaceuticals
HESTER BIOSCIENCES LTD.

Price Impact